401k Plan data: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN plan

CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 401k Plan overview

Plan Name	CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN
Plan identification number	001

CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

SYNEXUS CLINICAL RESEARCH US has sponsored the creation of one or more 401k plans.

Company Name: SYNEXUS CLINICAL RESEARCH US

Employer identification number (EIN): 943150948

NAIC Classification: 541700

Form 5500 Filing Information

Submission information for form 5500 for 401k plan CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2021-01-01
001 2021-01-01 SCOTT ALLEN
001 2020-01-01
001 2019-01-01
001 2017-01-01 CRAIG SMITH CRAIG SMITH 2018-10-15
001 2016-01-01 CRAIG J. SMITH CRAIG J SMITH 2017-10-13
001 2015-01-01 CRAIG SMITH
001 2014-01-01 DAVID M BRUGGEMAN
001 2013-01-01 DAVID M. BRUGGEMAN
001 2012-01-01 DAVID M. BRUGGEMAN
001 2011-01-01 DAVID BRUGGEMAN 2012-06-15
001 2010-01-01 JIM VESELY 2011-07-05
001 2009-01-01 JAMES VESELY

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2021-01-01
001	2021-01-01	SCOTT ALLEN
001	2020-01-01
001	2019-01-01
001	2017-01-01	CRAIG SMITH		CRAIG SMITH	2018-10-15
001	2016-01-01	CRAIG J. SMITH		CRAIG J SMITH	2017-10-13
001	2015-01-01	CRAIG SMITH
001	2014-01-01	DAVID M BRUGGEMAN
001	2013-01-01	DAVID M. BRUGGEMAN
001	2012-01-01	DAVID M. BRUGGEMAN
001	2011-01-01	DAVID BRUGGEMAN	2012-06-15
001	2010-01-01	JIM VESELY	2011-07-05
001	2009-01-01	JAMES VESELY

Plan Statistics for CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN

401k plan membership statisitcs for CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN

Measure Date Value
2021: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 637
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 0
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 0
Total of all active and inactive participants 2021-01-01 0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 0
Number of participants with account balances 2021-01-01 0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 585
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 474
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 162
Total of all active and inactive participants 2020-01-01 636
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 2
Total participants 2020-01-01 638
Number of participants with account balances 2020-01-01 554
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 78
2019: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 611
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 462
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 126
Total of all active and inactive participants 2019-01-01 588
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 1
Total participants 2019-01-01 589
Number of participants with account balances 2019-01-01 521
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 39
2017: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 597
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 467
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 116
Total of all active and inactive participants 2017-01-01 583
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 1
Total participants 2017-01-01 584
Number of participants with account balances 2017-01-01 493
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 49
2016: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 512
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 448
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 96
Total of all active and inactive participants 2016-01-01 544
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 544
Number of participants with account balances 2016-01-01 395
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 17
2015: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 531
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 423
Number of retired or separated participants receiving benefits 2015-01-01 1
Number of other retired or separated participants entitled to future benefits 2015-01-01 88
Total of all active and inactive participants 2015-01-01 512
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 512
Number of participants with account balances 2015-01-01 360
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 28
2014: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 469
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 426
Number of retired or separated participants receiving benefits 2014-01-01 1
Number of other retired or separated participants entitled to future benefits 2014-01-01 104
Total of all active and inactive participants 2014-01-01 531
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 531
Number of participants with account balances 2014-01-01 370
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 1
2013: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year 2013-01-01 211
Total number of active participants reported on line 7a of the Form 5500 2013-01-01 428
Number of retired or separated participants receiving benefits 2013-01-01 0
Number of other retired or separated participants entitled to future benefits 2013-01-01 26
Total of all active and inactive participants 2013-01-01 454
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-01-01 0
Total participants 2013-01-01 454
Number of participants with account balances 2013-01-01 165
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-01-01 4
2012: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year 2012-01-01 212
Total number of active participants reported on line 7a of the Form 5500 2012-01-01 189
Number of retired or separated participants receiving benefits 2012-01-01 0
Number of other retired or separated participants entitled to future benefits 2012-01-01 22
Total of all active and inactive participants 2012-01-01 211
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2012-01-01 0
Total participants 2012-01-01 211
Number of participants with account balances 2012-01-01 142
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2012-01-01 1
2009: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year 2009-01-01 54
Total number of active participants reported on line 7a of the Form 5500 2009-01-01 54
Number of retired or separated participants receiving benefits 2009-01-01 0
Number of other retired or separated participants entitled to future benefits 2009-01-01 8
Total of all active and inactive participants 2009-01-01 62
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2009-01-01 0
Total participants 2009-01-01 62
Number of participants with account balances 2009-01-01 55
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2009-01-01 2

Measure	Date	Value
2021: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	637
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	0
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	0
Total of all active and inactive participants	2021-01-01	0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	0
Number of participants with account balances	2021-01-01	0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	585
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	474
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	162
Total of all active and inactive participants	2020-01-01	636
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	2
Total participants	2020-01-01	638
Number of participants with account balances	2020-01-01	554
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	78
2019: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	611
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	462
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	126
Total of all active and inactive participants	2019-01-01	588
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	1
Total participants	2019-01-01	589
Number of participants with account balances	2019-01-01	521
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	39
2017: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	597
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	467
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	116
Total of all active and inactive participants	2017-01-01	583
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	1
Total participants	2017-01-01	584
Number of participants with account balances	2017-01-01	493
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	49
2016: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	512
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	448
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	96
Total of all active and inactive participants	2016-01-01	544
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	544
Number of participants with account balances	2016-01-01	395
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	17
2015: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	531
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	423
Number of retired or separated participants receiving benefits	2015-01-01	1
Number of other retired or separated participants entitled to future benefits	2015-01-01	88
Total of all active and inactive participants	2015-01-01	512
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	512
Number of participants with account balances	2015-01-01	360
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	28
2014: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	469
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	426
Number of retired or separated participants receiving benefits	2014-01-01	1
Number of other retired or separated participants entitled to future benefits	2014-01-01	104
Total of all active and inactive participants	2014-01-01	531
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	531
Number of participants with account balances	2014-01-01	370
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	1
2013: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year	2013-01-01	211
Total number of active participants reported on line 7a of the Form 5500	2013-01-01	428
Number of retired or separated participants receiving benefits	2013-01-01	0
Number of other retired or separated participants entitled to future benefits	2013-01-01	26
Total of all active and inactive participants	2013-01-01	454
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-01-01	0
Total participants	2013-01-01	454
Number of participants with account balances	2013-01-01	165
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-01-01	4
2012: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2012 401k membership
Total participants, beginning-of-year	2012-01-01	212
Total number of active participants reported on line 7a of the Form 5500	2012-01-01	189
Number of retired or separated participants receiving benefits	2012-01-01	0
Number of other retired or separated participants entitled to future benefits	2012-01-01	22
Total of all active and inactive participants	2012-01-01	211
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2012-01-01	0
Total participants	2012-01-01	211
Number of participants with account balances	2012-01-01	142
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2012-01-01	1
2009: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2009 401k membership
Total participants, beginning-of-year	2009-01-01	54
Total number of active participants reported on line 7a of the Form 5500	2009-01-01	54
Number of retired or separated participants receiving benefits	2009-01-01	0
Number of other retired or separated participants entitled to future benefits	2009-01-01	8
Total of all active and inactive participants	2009-01-01	62
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2009-01-01	0
Total participants	2009-01-01	62
Number of participants with account balances	2009-01-01	55
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2009-01-01	2

Financial Data on CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN

Measure	Date	Value
2021 : CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-07-31	$0
Total transfer of assets to this plan	2021-07-31	$0
Total transfer of assets from this plan	2021-07-31	$25,794,295
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-07-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-07-31	$0
Total income from all sources (including contributions)	2021-07-31	$4,440,141
Total loss/gain on sale of assets	2021-07-31	$0
Total of all expenses incurred	2021-07-31	$2,068,072
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-07-31	$2,005,858
Expenses. Certain deemed distributions of participant loans	2021-07-31	$35,462
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-07-31	$1,697,789
Value of total assets at end of year	2021-07-31	$0
Value of total assets at beginning of year	2021-07-31	$23,422,226
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-07-31	$26,752
Total interest from all sources	2021-07-31	$9,360
Total dividends received (eg from common stock, registered investment company shares)	2021-07-31	$531,045
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-07-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-07-31	$531,045
Was this plan covered by a fidelity bond	2021-07-31	Yes
Value of fidelity bond cover	2021-07-31	$500,000
If this is an individual account plan, was there a blackout period	2021-07-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-07-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-07-31	No
Contributions received from participants	2021-07-31	$1,201,303
Participant contributions at beginning of year	2021-07-31	$268,122
Income. Received or receivable in cash from other sources (including rollovers)	2021-07-31	$130,646
Other income not declared elsewhere	2021-07-31	$24
Administrative expenses (other) incurred	2021-07-31	$26,752
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-07-31	No
Value of net income/loss	2021-07-31	$2,372,069
Value of net assets at end of year (total assets less liabilities)	2021-07-31	$0
Value of net assets at beginning of year (total assets less liabilities)	2021-07-31	$23,422,226
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-07-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-07-31	No
Were any leases to which the plan was party in default or uncollectible	2021-07-31	No
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-07-31	$21,922,674
Interest on participant loans	2021-07-31	$9,360
Value of interest in common/collective trusts at beginning of year	2021-07-31	$1,231,430
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-07-31	$2,189,305
Net investment gain or loss from common/collective trusts	2021-07-31	$12,618
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-07-31	No
Was there a failure to transmit to the plan any participant contributions	2021-07-31	No
Has the plan failed to provide any benefit when due under the plan	2021-07-31	No
Contributions received in cash from employer	2021-07-31	$365,840
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-07-31	$2,005,858
Did the plan have assets held for investment	2021-07-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-07-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-07-31	Yes
Opinion of an independent qualified public accountant for this plan	2021-07-31	Disclaimer
Accountancy firm name	2021-07-31	LOHMAN COMPANY, PLLC
Accountancy firm EIN	2021-07-31	860985325
2020 : CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total transfer of assets to this plan	2020-12-31	$0
Total transfer of assets from this plan	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$6,675,869
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$2,794,978
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$2,756,276
Expenses. Certain deemed distributions of participant loans	2020-12-31	$1,672
Value of total corrective distributions	2020-12-31	$329
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$2,852,291
Value of total assets at end of year	2020-12-31	$23,422,226
Value of total assets at beginning of year	2020-12-31	$19,541,335
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$36,701
Total interest from all sources	2020-12-31	$15,705
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$962,704
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$962,704
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$1,739,038
Participant contributions at end of year	2020-12-31	$268,122
Participant contributions at beginning of year	2020-12-31	$265,058
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$378,677
Other income not declared elsewhere	2020-12-31	$830
Administrative expenses (other) incurred	2020-12-31	$36,701
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$3,880,891
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$23,422,226
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$19,541,335
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$21,922,674
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$18,164,552
Interest on participant loans	2020-12-31	$15,705
Value of interest in common/collective trusts at end of year	2020-12-31	$1,231,430
Value of interest in common/collective trusts at beginning of year	2020-12-31	$1,111,725
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$2,820,144
Net investment gain or loss from common/collective trusts	2020-12-31	$24,195
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$734,576
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$2,756,276
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	LOHMAN COMPANY, PLLC
Accountancy firm EIN	2020-12-31	860985325
2019 : CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$0
Total transfer of assets from this plan	2019-12-31	$0
Total transfer of assets from this plan	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$6,011,030
Total income from all sources (including contributions)	2019-12-31	$6,011,030
Total loss/gain on sale of assets	2019-12-31	$0
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$2,840,056
Total of all expenses incurred	2019-12-31	$2,840,056
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$2,763,181
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$2,763,181
Expenses. Certain deemed distributions of participant loans	2019-12-31	$5,790
Expenses. Certain deemed distributions of participant loans	2019-12-31	$5,790
Value of total corrective distributions	2019-12-31	$6
Value of total corrective distributions	2019-12-31	$6
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$2,110,364
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$2,110,364
Value of total assets at end of year	2019-12-31	$19,541,335
Value of total assets at end of year	2019-12-31	$19,541,335
Value of total assets at beginning of year	2019-12-31	$16,370,361
Value of total assets at beginning of year	2019-12-31	$16,370,361
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$71,079
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$71,079
Total interest from all sources	2019-12-31	$13,837
Total interest from all sources	2019-12-31	$13,837
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$1,040,172
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$1,040,172
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$1,040,172
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$1,040,172
Was this plan covered by a fidelity bond	2019-12-31	Yes
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$1,816,222
Contributions received from participants	2019-12-31	$1,816,222
Participant contributions at end of year	2019-12-31	$265,058
Participant contributions at end of year	2019-12-31	$265,058
Participant contributions at beginning of year	2019-12-31	$244,019
Participant contributions at beginning of year	2019-12-31	$244,019
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$75,836
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$75,836
Other income not declared elsewhere	2019-12-31	$13,599
Other income not declared elsewhere	2019-12-31	$13,599
Administrative expenses (other) incurred	2019-12-31	$71,079
Administrative expenses (other) incurred	2019-12-31	$71,079
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$3,170,974
Value of net income/loss	2019-12-31	$3,170,974
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$19,541,335
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$19,541,335
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$16,370,361
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$16,370,361
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$18,164,552
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$18,164,552
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$16,126,342
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$16,126,342
Interest on participant loans	2019-12-31	$13,837
Value of interest in common/collective trusts at end of year	2019-12-31	$1,111,725
Value of interest in common/collective trusts at end of year	2019-12-31	$1,111,725
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$2,810,305
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$2,810,305
Net investment gain or loss from common/collective trusts	2019-12-31	$22,753
Net investment gain or loss from common/collective trusts	2019-12-31	$22,753
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$218,306
Contributions received in cash from employer	2019-12-31	$218,306
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$2,763,181
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$2,763,181
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	LOHMAN COMPANY, PLLC
Accountancy firm name	2019-12-31	LOHMAN COMPANY, PLLC
Accountancy firm EIN	2019-12-31	860985325
Accountancy firm EIN	2019-12-31	860985325
2018 : CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total transfer of assets to this plan	2018-12-31	$0
Total transfer of assets from this plan	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$1,574,536
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$2,861,375
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$2,706,754
Expenses. Certain deemed distributions of participant loans	2018-12-31	$3,146
Value of total corrective distributions	2018-12-31	$16,942
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$2,222,595
Value of total assets at end of year	2018-12-31	$16,370,361
Value of total assets at beginning of year	2018-12-31	$17,657,200
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$134,533
Total interest from all sources	2018-12-31	$11,274
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$1,287,604
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$1,287,604
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$1,751,272
Participant contributions at end of year	2018-12-31	$244,019
Participant contributions at beginning of year	2018-12-31	$199,051
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$258,463
Other income not declared elsewhere	2018-12-31	$44,022
Administrative expenses (other) incurred	2018-12-31	$134,533
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$-1,286,839
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$16,370,361
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$17,657,200
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$16,126,342
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$17,458,149
Interest on participant loans	2018-12-31	$11,274
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-1,990,959
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$212,860
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$2,706,754
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	LOHMAN COMPANY, PLLC
Accountancy firm EIN	2018-12-31	860985325
2017 : CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total transfer of assets to this plan	2017-12-31	$544,099
Total transfer of assets from this plan	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$4,584,868
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$1,331,252
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$1,214,648
Expenses. Certain deemed distributions of participant loans	2017-12-31	$5,828
Value of total corrective distributions	2017-12-31	$61,720
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$2,051,567
Value of total assets at end of year	2017-12-31	$17,657,200
Value of total assets at beginning of year	2017-12-31	$13,859,485
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$49,056
Total interest from all sources	2017-12-31	$8,578
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$1,094,922
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$1,094,922
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$500,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$1,454,432
Participant contributions at end of year	2017-12-31	$199,051
Participant contributions at beginning of year	2017-12-31	$187,716
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$442,562
Other income not declared elsewhere	2017-12-31	$287
Administrative expenses (other) incurred	2017-12-31	$49,056
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$3,253,616
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$17,657,200
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$13,859,485
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$17,458,149
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$13,671,769
Interest on participant loans	2017-12-31	$8,578
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$1,429,514
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$154,573
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$1,214,648
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	LOHMAN COMPANY, PLLC
Accountancy firm EIN	2017-12-31	860985325
2016 : CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total transfer of assets to this plan	2016-12-31	$0
Total transfer of assets from this plan	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$2,174,253
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$1,916,203
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$1,810,742
Expenses. Certain deemed distributions of participant loans	2016-12-31	$2,591
Value of total corrective distributions	2016-12-31	$45,430
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$1,437,033
Value of total assets at end of year	2016-12-31	$13,859,485
Value of total assets at beginning of year	2016-12-31	$13,601,435
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$57,440
Total interest from all sources	2016-12-31	$6,293
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$678,777
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$678,777
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$500,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$1,263,159
Participant contributions at end of year	2016-12-31	$187,716
Participant contributions at beginning of year	2016-12-31	$159,601
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$51,208
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2016-12-31	$1,033
Other income not declared elsewhere	2016-12-31	$26,475
Administrative expenses (other) incurred	2016-12-31	$57,440
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$258,050
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$13,859,485
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$13,601,435
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$13,671,769
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$13,005,272
Interest on participant loans	2016-12-31	$6,293
Value of interest in common/collective trusts at beginning of year	2016-12-31	$436,562
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$24,085
Net investment gain or loss from common/collective trusts	2016-12-31	$1,590
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$122,666
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$1,809,709
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	LOHMAN COMPANY, PLLC
Accountancy firm EIN	2016-12-31	860985325
2015 : CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total transfer of assets to this plan	2015-12-31	$0
Total transfer of assets from this plan	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$1,912,187
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$1,757,941
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$1,636,528
Expenses. Certain deemed distributions of participant loans	2015-12-31	$22,117
Value of total corrective distributions	2015-12-31	$54,180
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$1,824,030
Value of total assets at end of year	2015-12-31	$13,601,435
Value of total assets at beginning of year	2015-12-31	$13,447,189
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$45,116
Total interest from all sources	2015-12-31	$10,694
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$1,127,728
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$1,127,728
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$500,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$1,259,260
Participant contributions at end of year	2015-12-31	$159,601
Participant contributions at beginning of year	2015-12-31	$307,086
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$271,957
Other income not declared elsewhere	2015-12-31	$15,206
Administrative expenses (other) incurred	2015-12-31	$45,116
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$154,246
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$13,601,435
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$13,447,189
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$13,005,272
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$12,792,556
Interest on participant loans	2015-12-31	$10,694
Value of interest in common/collective trusts at end of year	2015-12-31	$436,562
Value of interest in common/collective trusts at beginning of year	2015-12-31	$347,547
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-1,071,177
Net investment gain or loss from common/collective trusts	2015-12-31	$5,706
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$292,813
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$1,636,528
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	LOHMAN COMPANY, PLLC
Accountancy firm EIN	2015-12-31	860985325
2014 : CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total transfer of assets from this plan	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$2,512,250
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$1,529,466
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$1,412,998
Expenses. Certain deemed distributions of participant loans	2014-12-31	$33,491
Value of total corrective distributions	2014-12-31	$25,287
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$1,648,793
Value of total assets at end of year	2014-12-31	$13,447,189
Value of total assets at beginning of year	2014-12-31	$12,464,405
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$57,690
Total interest from all sources	2014-12-31	$13,053
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$822,784
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$822,784
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$500,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$1,242,712
Participant contributions at end of year	2014-12-31	$307,086
Participant contributions at beginning of year	2014-12-31	$97,813
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$403,930
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2014-12-31	$11,634
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2014-12-31	$7,148,213
Other income not declared elsewhere	2014-12-31	$5,202
Administrative expenses (other) incurred	2014-12-31	$57,690
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$982,784
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$13,447,189
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$12,464,405
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$12,792,556
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$5,218,379
Interest on participant loans	2014-12-31	$13,053
Value of interest in common/collective trusts at end of year	2014-12-31	$347,547
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$-4,419
Net investment gain or loss from common/collective trusts	2014-12-31	$26,837
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$2,151
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$1,401,364
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	LOHMAN COMPANY, PLLC
Accountancy firm EIN	2014-12-31	860985325
2013 : CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total transfer of assets to this plan	2013-12-31	$7,148,213
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$1,986,664
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$392,987
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$386,445
Expenses. Certain deemed distributions of participant loans	2013-12-31	$3,316
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$1,060,963
Value of total assets at end of year	2013-12-31	$12,464,405
Value of total assets at beginning of year	2013-12-31	$3,722,515
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$3,226
Total interest from all sources	2013-12-31	$3,546
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$198,230
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$198,230
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$373,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$546,544
Participant contributions at end of year	2013-12-31	$97,813
Participant contributions at beginning of year	2013-12-31	$70,872
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$225,456
Value of other receiveables (less allowance for doubtful accounts) at end of year	2013-12-31	$7,148,213
Other income not declared elsewhere	2013-12-31	$237
Administrative expenses (other) incurred	2013-12-31	$3,226
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$1,593,677
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$12,464,405
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$3,722,515
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$5,218,379
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$3,651,643
Interest on participant loans	2013-12-31	$3,546
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$723,688
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$288,963
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$386,445
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	LOHMAN COMPANY, PLLC
Accountancy firm EIN	2013-12-31	860985325
2012 : CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets	2012-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2012-12-31	$0
Total income from all sources (including contributions)	2012-12-31	$1,205,616
Total loss/gain on sale of assets	2012-12-31	$0
Total of all expenses incurred	2012-12-31	$113,831
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2012-12-31	$111,506
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2012-12-31	$867,041
Value of total assets at end of year	2012-12-31	$3,722,515
Value of total assets at beginning of year	2012-12-31	$2,630,730
Total of administrative expenses incurred including professional, contract, advisory and management fees	2012-12-31	$2,325
Total interest from all sources	2012-12-31	$2,260
Total dividends received (eg from common stock, registered investment company shares)	2012-12-31	$88,146
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2012-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2012-12-31	$88,146
Was this plan covered by a fidelity bond	2012-12-31	Yes
Value of fidelity bond cover	2012-12-31	$264,000
If this is an individual account plan, was there a blackout period	2012-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2012-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2012-12-31	No
Contributions received from participants	2012-12-31	$494,169
Participant contributions at end of year	2012-12-31	$70,872
Participant contributions at beginning of year	2012-12-31	$47,918
Income. Received or receivable in cash from other sources (including rollovers)	2012-12-31	$109,594
Administrative expenses (other) incurred	2012-12-31	$2,325
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Value of net income/loss	2012-12-31	$1,091,785
Value of net assets at end of year (total assets less liabilities)	2012-12-31	$3,722,515
Value of net assets at beginning of year (total assets less liabilities)	2012-12-31	$2,630,730
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2012-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2012-12-31	No
Were any leases to which the plan was party in default or uncollectible	2012-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2012-12-31	$3,651,643
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2012-12-31	$2,493,058
Interest on participant loans	2012-12-31	$2,260
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2012-12-31	$89,754
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2012-12-31	$89,754
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2012-12-31	$248,169
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2012-12-31	No
Was there a failure to transmit to the plan any participant contributions	2012-12-31	No
Has the plan failed to provide any benefit when due under the plan	2012-12-31	No
Contributions received in cash from employer	2012-12-31	$263,278
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2012-12-31	$111,506
Did the plan have assets held for investment	2012-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2012-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2012-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2012-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2012-12-31	Disclaimer
Accountancy firm name	2012-12-31	LOHMAN COMPANY, PLLC
Accountancy firm EIN	2012-12-31	860985325
2009 : CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2009-12-31	$0

Form 5500 Responses for CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN

2021: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	Yes
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2017: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2013 form 5500 responses
2013-01-01	Type of plan entity	Single employer plan
2013-01-01	Submission has been amended	No
2013-01-01	This submission is the final filing	No
2013-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2013-01-01	Plan is a collectively bargained plan	No
2013-01-01	Plan funding arrangement – Trust	Yes
2013-01-01	Plan benefit arrangement - Trust	Yes
2012: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2012 form 5500 responses
2012-01-01	Type of plan entity	Single employer plan
2012-01-01	Submission has been amended	No
2012-01-01	This submission is the final filing	No
2012-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2012-01-01	Plan is a collectively bargained plan	No
2012-01-01	Plan funding arrangement – Trust	Yes
2012-01-01	Plan benefit arrangement - Trust	Yes
2009: CLINICAL RESEARCH ADVANTAGE, INC 401(K) PLAN 2009 form 5500 responses
2009-01-01	Type of plan entity	Single employer plan
2009-01-01	Submission has been amended	No
2009-01-01	This submission is the final filing	No
2009-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2009-01-01	Plan is a collectively bargained plan	No
2009-01-01	Plan funding arrangement – Trust	Yes
2009-01-01	Plan benefit arrangement - Trust	Yes

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	SYNEXUS CLINICAL RESEARCH US
Employer identification number (EIN):	943150948
NAIC Classification:	541700